Asymmetry Capital Management’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Asymmetry Capital Management’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-477,621	Closed	-$1.06M	–	44
2017 Q4	$1.06M	Buy	477,621 +206,519	+76%	+$513K	1.45%	20
2017 Q3	$786K	Sell	271,102 -101,592	-27%	-$347K	0.91%	30
2017 Q2	$1.66M	Sell	372,694 -719,074	-66%	-$2.97M	1.97%	19
2017 Q1	$5.09M	Buy	1,091,768 +536,683	+97%	+$3.11M	7.09%	3
2016 Q4	$3.38M	Buy	555,085 +216,017	+64%	+$1.13M	6.28%	7
2016 Q3	$1.87M	Buy	339,068 +40,878	+14%	+$191K	3.25%	13
2016 Q2	$1.13M	Buy	+298,190	New	+$1.01M	2.08%	19
2016 Q1	–	Sell	-303,157	Closed	-$1.72M	–	21
2015 Q4	$1.72M	Buy	303,157 +100,002	+49%	+$610K	2.6%	17
2015 Q3	$1.08M	Buy	+203,155	New	+$1.57M	2.4%	20

Other funds holding SGYP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Hikari Power Tokyo, Japan $855M AUM 14.24% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Asymmetry Capital Management's SGYP Position: Q1 2018 in Review

Asymmetry Capital Management sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2018, closing a stake of 477,621 shares — an estimated $1.06M sold.

Asymmetry Capital Management first reported a position in SGYP in Q3 2015 and held it in 9 quarters. The position peaked at $5.09M in Q1 2017. 147 funds tracked by Wall St. Rank hold SGYP as of Q1 2018.

Asymmetry Capital Management reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2018 after selling out during the quarter.
Asymmetry Capital Management sold 477,621 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2018, an estimated $1.06M.
Asymmetry Capital Management first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q3 2015 and held it in 9 quarters.
Asymmetry Capital Management's Synergy Pharmaceuticals, Inc Common Stock position peaked at $5.09M in Q1 2017.
147 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2018.

Based on Asymmetry Capital Management's 13F filing for Q1 2018, filed 9 May 2018.